The chronic exposure to immunosuppressive agents represents a unique risk factor to kidney transplant recipients, attributed to the toxic or inhibitory (possibly reversible) effects of these drugs to pancreatic islet beta cells and manifesting as insulin resistance or impaired insulin secretion (75–80). Here, INS is linked to Insulin resistance.